November 3rd 2024 – Thank you Shi-Yong for the invitation to speak. Sunday morning was well spent sharing the team’s research on oncofetal proteins in maintaining a more stemness state in HCC at the Anti-Cancer Together (ACT) Online Forum.

Stephanie shared the team’s latest findings on the discovery of potential therapies for CTNNB1 mutation-driven HCC using a genetically defined, syngeneic mouse organoid platform at this year’s SKLLR Symposium, held on October 16th, 2024, at Renaissance Harbor View Hotel HK.

Thank you Yan Yan of Huazhong Agricultural University for the invitation to speak at this international symposium. Saturday afternoon well spent in an engaging session on mechanisms of tumorigenesis and prevention strategies.

Sept 19-21, 2024 – 83rd Annual Meeting of JCA at Fukuoka, Japan

Stephanie gave a talk in the International Session on ‘”Cellular Plasticity: How do cancer cells rewire molecular, biochemical and phenotypic pathways for adapting to malignant progression?”. Thank you Wai-Leong Tam and Hiromichi Ebi for the invitation to speak. A pleasure to meet both in person and reconnect with old friends.

June 10-13, 2024 with Huanwen, Huajian and Jia.

April 5-10, 2024 with Johnson, Ianto, Venus, Angel, Elok and Matt.

March 22, 2024 – Thankful for the opportunity to reconnect with Lena and Ming and to give a seminar at The First Affiliated Hospital of Sun Yat-Sen University in Guangzhou this past March.

March 8, 2024 – Stephanie shared the team’s latest research at the first sub-conference of the Young Academy of Sciences Summit (YASS) held at CUHK. Under the theme “Life Science”, the sub-conference focused on emerging technologies in regenerative medicine and the application of stem cells in the treatment of diseases.

Sept 24-25, 2023 – Advancing Cancer Prevention & Treatment in Greater Bay Areas

Happy to have the opportunity to participate in this conference organized by Prof. Anne Lee and Prof. XY Guan and shared about our recent cancer cell plasticity findings.